RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 34-44
  • AstraZeneca looks to EU decision for next cancer drug boost

    LONDON (Reuters) - AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer. European Medicines...
  • Geographic split likely for GSK mature drugs sale: sources

    LONDON (Reuters) - GlaxoSmithKline is seeking binding bids by next month for a range of older drugs worth more than $3 billion, which it is likely to sell by geographical region, according to people with direct knowledge of the process. Potential bidders...
  • How to judge Medicare plans

    How to judge Medicare plans
    While much of the nation is preoccupied with Obamacare and picking new health insurance at work, older Americans have deadlines of their own coming up — involving Medicare. We're just a few days away from the two-month period when the nation's...
  • Stada secures third license for copycat biotech drug: CEO

    BAD VILBEL Germany (Reuters) - Germany's Stada plans to bring a copy of Eli Lilly's Forteo osteoporosis treatment to market, its chief executive said, as the generic drugmaker moves further into the sale of cheaper alternatives for costly biotech drugs....
  • Exclusive: Top Actavis holder, Fidelity, adds Allergan holdings- sources

    NEW YORK/BOSTON (Reuters) - Fidelity Investments, the largest shareholder in Actavis Plc , has increased its holdings in takeover-target Allergan in recent months and would be supportive of a potential merger between the two drugmakers, according to...
  • U.S. maker of experimental Ebola drug ZMapp seeks to boost output

    (Reuters) - California-based Mapp Biopharmaceutical Inc is making progress in efforts to boost production of the experimental Ebola treatment ZMapp, as the deadly virus continues to spread through West Africa and beyond, the company said Friday. The...
  • U.S. FDA approves Gilead's $94,500 hepatitis C drug

    (Reuters) - U.S. regulators on Friday approved a new hepatitis C pill from Gilead Sciences Inc, which said it will charge $94,500 for an improved 12-week course of treatment to rid patients of the liver-destroying viral infection. The daily pill, to be...
  • Stock option volumes soar for biotechs with Ebola drugs

    NEW YORK (Reuters) - The newest twist in the business of trying to capitalize on the outbreak of the Ebola virus is playing out in the U.S. equity options market. Trading volumes have soared in the stock options of a pair of biotechnology companies...
  • Untested stimulant found in dietary supplements: study

    NEW YORK (Reuters Health) – At least a dozen dietary supplements available in the U.S. contain a potentially-dangerous synthetic stimulant that has never been tested on humans, says a new study. The inclusion of the stimulant known as DMBA in...
  • Endo says Auxilium Pharmaceuticals has agreed to $2.6B purchase

    PHILADELPHIA Drugmaker Endo International P.L.C, run largely from Malvern, Pa., but incorporated in Ireland, said Thursday that it has convinced directors of Auxilium Pharmaceuticals, a Chesterbrook, Pa.-based maker of testosterone-replacement...
  • Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana

    Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana
    Nazareth police said an undercover drug buy Wednesday netted more than 50 bags of heroin, prescription painkillers and synthetic marijuana. Pedro Alexander Vera, 25, of the 1200 block of Livingston Street, Bethlehem, is charged with manufacturing...